Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Kazuhiro Koikawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3208-9447; OpenAlex author ID A5016781693. Sources: OpenAlex.

Their work

Papers
13
Trials
0
Grants
0
Labs led
0
Collaborators
38
Papers, trials and grants by year

2017: 5 papers · 2018: 2 papers · 2019: 2 papers · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: 2 papers

Papers 13

  1. Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cance… Co-author DOI 10.1158/0008-5472.can-24-0830↗
  2. Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells. Co-author DOI 10.1186/s13046-024-03060-5↗
  3. Bone marrow-derived macrophages converted into cancer-associated fibroblast-like cells promote pancreatic cancer progression. Co-author DOI 10.1016/j.canlet.2021.04.013↗
  4. Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy. Co-author DOI 10.1016/j.cell.2021.07.020↗
  5. Cancer-associated acinar-to-ductal metaplasia within the invasive front of pancreatic cancer contributes to local invasion. Co-author DOI 10.1016/j.canlet.2018.12.005↗
  6. S100P regulates the collective invasion of pancreatic cancer cells into the lymphatic endothelial monolayer. Co-author DOI 10.3892/ijo.2019.4812↗
  7. Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180. Co-author DOI 10.1016/j.canlet.2017.10.010↗
  8. Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2018.03.031↗
  9. Autophagy inhibition enhances antiproliferative effect of salinomycin in pancreatic cancer cells. Co-author DOI 10.1016/j.pan.2017.08.009↗
  10. Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mi… Co-author DOI 10.1053/j.gastro.2017.01.010↗
  11. Extra-pancreatic invasion induces lipolytic and fibrotic changes in the adipose microenvironment, with released fatty acids enhancing the invasiveness of pancr… Co-author DOI 10.18632/oncotarget.15430↗
  12. Cancer-associated peritoneal mesothelial cells lead the formation of pancreatic cancer peritoneal dissemination. Co-author DOI 10.3892/ijo.2016.3829↗
  13. Degree of desmoplasia in metastatic lymph node lesions is associated with lesion size and poor prognosis in pancreatic cancer patients. Co-author DOI 10.3892/ol.2017.6549↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kenoki Ohuchida · 13 shared papers, 2017–2024 · strength 1.05
  2. Kohei Nakata · 12 shared papers, 2017–2024 · strength 0.96
  3. Masafumi Nakamura · 10 shared papers, 2017–2024 · strength 0.88
  4. Toshiya Abe · 11 shared papers, 2017–2024 · strength 0.86
  5. Chika Iwamoto · 8 shared papers, 2017–2024 · strength 0.72
  6. Takashi Okumura · 10 shared papers, 2017–2021 · strength 0.65
  7. Yoshihiro Miyasaka · 10 shared papers, 2017–2021 · strength 0.65
  8. Takao Ohtsuka · 10 shared papers, 2017–2021 · strength 0.65
  9. Yoshinao Oda · 7 shared papers, 2017–2024 · strength 0.64
  10. Sho Endo · 9 shared papers, 2017–2019 · strength 0.54
  11. Yohei Ando · 6 shared papers, 2017–2021 · strength 0.43
  12. Hiromichi Nakayama · 7 shared papers, 2017–2019 · strength 0.43
  13. Shin Takesue · 7 shared papers, 2017–2019 · strength 0.43
  14. Shin Kibe · 6 shared papers, 2017–2021 · strength 0.42
  15. Naoki Ikenaga · 3 shared papers, 2021–2024 · strength 0.42
  16. Akiko Sagara · 4 shared papers, 2017–2024 · strength 0.40
  17. Masataka Hayashi · 2 shared papers, 2024 · strength 0.32
  18. Koki Oyama · 2 shared papers, 2024 · strength 0.32
  19. Haizhen Luo · 2 shared papers, 2024 · strength 0.32
  20. Takashi Morisaki · 2 shared papers, 2024 · strength 0.32
  21. Pingshan Zhong · 2 shared papers, 2024 · strength 0.32
  22. Makoto Hashizume · 5 shared papers, 2017–2018 · strength 0.29
  23. Tomohiko Shinkawa · 2 shared papers, 2021–2024 · strength 0.26
  24. Masafumi Sada · 4 shared papers, 2017–2018 · strength 0.22
  25. Koji Shindo · 2 shared papers, 2019–2021 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.